Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Market Vectors Biotech (NYSE: BBH) In Long Term Uptrend

|Includes: VanEck Vectors Biotech ETF (BBH)

August 13, 2012 (By Frank Kollar)

Shares of the Exchange Traded Fund Market Vectors Biotech (NYSE: BBH) may have the reputation of being volatile, but for those looking for a strong current uptrend, BBH fits the bill.

Since hitting correction lows at $29.33 back on August 7, 2011, BBH has risen steadily over the past year to $49.66 as of Monday, August 12 near the close. This 69% gain puts the biotech sector near the top in performance.

Chart Courtesy of

There is still some volatility and buyers of this ETF should be prepared for 5% to 8% pullbacks. A trailing stop around 10% should protect against a further corrective movement.

Even lower risk would be had with a stop at $47 a share, the July 24 correction low.

The ( ETF Timing Strategy does have a position in Market Vectors Biotech.

Disclosure: I am long BBH.